Medicure (MCUJF) Short term Debt (2011 - 2025)

Medicure (MCUJF) posted quarterly Short term Debt of $278229.5 for Q4 2025, down 0.55% quarter-over-quarter from $279754.5 in Q3 2025.

Medicure (MCUJF) Short term Debt (2011 - 2025) Analysis & Trends

Medicure's Short term Debt history runs 14 years deep, the most recent figure standing at $278229.5 for Q4 2025.

In Q4 2025, Short term Debt changed N/A year-over-year to $278229.5; the TTM figure through Dec 2025 stood at $278229.5 (changed N/A YoY), while the FY2025 annual figure was $277699.9, changed N/A from the prior year.
Short term Debt for Q4 2025 stood at $278229.5, down from $279754.5 in the prior quarter.
The five-year high for Short term Debt was $966001.7 in Q3 2021, with the low at $50299.4 in Q1 2023.
The 4-year median for Short term Debt is $470527.3 (2022), against an average of $493037.0.
The sharpest annual moves came in 2021 and 2023: Short term Debt rose 11.16% in 2021, then plunged 89.31% in 2023.
Medicure's Short term Debt stood at $468861.6 in 2021, then climbed by 6.37% to $498747.9 in 2022, then slumped by 89.91% to $50299.4 in 2023, then soared by 453.15% to $278229.5 in 2025.
Business Quant data shows MCUJF's Short term Debt at $278229.5 in Q4 2025, $279754.5 in Q3 2025, and $265590.2 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Medicure	97.06 Mn	95.93 Mn	2.57 Mn

Download Data